Gynaecology Pathway Board Gynaecology Pathway Board

NCA Gynaecology Pathway Board (NCGPB)

North Region Health & Care Collaboration North Region Health & Care Collaboration North Region Health & Care Collaboration North Region Health & Care Collaboration North Region Health & Care Collaboration North Region Health & Care Collaboration

Gynaecology Pathway Board

The Pathway Board brings together healthcare professionals, clinical leaders, and multi-agency representatives to enhance patient outcomes, ensure service quality, and promote equitable care across the region.

Gynaecological cancer services in the North

There are a number of Gynaecological cancers that affect women in Scotland each year. Ovarian is the most common with around 600 new cases in Scotland each year. Other Gynaecological cancers include Cervix, Endometrial and Vulval.

The treatment and management of these cancers differs by type. In the North, Gynaecological cancer services are available from our three main centres; Aberdeen, Dundee and Inverness. For patients requiring surgery for advanced disease, this is carried out at Aberdeen Royal Infirmary (ARI) for patients in the North.

The aim of this Pathway Board is to facilitate regional working between the centres, ensuring a focus on improving patient outcomes.

For more information on the symptoms, investigation and treatment of gynaecological cancers, please visit the NHS Inform website.

Pathway Board details

Clinical Director Dr Ann-Maree Kennedy, Consultant Clinical Oncologist, NHS Grampian
Terms of Reference Published November 2023

 Clinical Management Guidelines (CMGs)

Title Published
Ovarian Cancer In Development
Endometrial Cancer In Development
Cervical Cancer In Development
Vulval Cancer In Development

Other Guidelines

SIGN Guideline 135 - Management of Epithelial Ovarian Cancer
Scottish Cancer Referral Guidelines - Gynaecological Cancers
Scottish Palliative Care Guidelines
Scottish Clinical Biochemistry Guidelines
Scottish Gynaeoncology Managed Clinical Networks Ovarian Cancer Staging Guideline July 2023

North of Scotland Quality Performance Indicator (QPI) Annual Reports

Cervical

Cervical Cancer QPI Annual Report (2021-22 patients)
Cervical Cancer QPI Annual Report (2020-21 patients)
Cervical Cancer QPI Annual Report (2019-20 patients)
Cervical Cancer QPI Annual Report (2018-19 patients)
Cervical Cancer QPI Annual Report (2017-18 patients)
Cervical Cancer QPI Annual Report (2015-16 patients)
Cervical Cancer QPI Annual Report (2014-15 patients)

Endometrial

Endometrial Cancer QPI Annual Report (2021-22 patients)
Endometrial Cancer QPI Annual Report (2020-21 patients)
Endometrial Cancer QPI Annual Report (2019-20 patients)
Endometrial Cancer QPI Annual Report (2018-19 patients)
Endometrial Cancer QPI Annual Report (2017-18 patients)
Endometrial Cancer QPI Annual Report (2015-16 patients)
Endometrial Cancer QPI Annual Report (2014-15 patients)

Ovarian

Ovarian Cancer QPI Annual Report (2021-22 patients)
Ovarian Cancer QPI Annual Report (2020-21 patients)
Ovarian Cancer QPI Annual Report (2019-20 patients)
Ovarian Cancer QPI Annual Report (2018-19 patients)
Ovarian Cancer QPI Annual Report (2017-18 patients)
Ovarian Cancer QPI Annual Report (2016-17 patients)
Ovarian Cancer QPI Annual Report (2014-15 patients)
Ovarian Cancer QPI Annual Report (2013-14 patients)

Quality Performance Indicator (QPI) National Reports

Cervial

Cervial Cancer QPI National Report (2017-20 patients)
Cervial and Endometrial Cancer National Report (2014-17 patients)

Endometrial

Endometrial Cancer QPI National Report (2017-20 patients)
Cervical and Endometrial Cancer National Report (2014-17 patients)

Ovarian

Ovarian Cancer QPI National Report (2016-19 patients)
Ovarian Cancer QPI National Report (2013-16 patients)

Other Reports

North of Scotland Ovarian Cancer Action Plan Progress Report January 2023
North of Scotland Ovarian Cancer Action Plan Progress Report March 2022